Literature DB >> 15623480

Prognostic relevance of extensive necrosis in renal cell carcinoma.

V Foria1, T Surendra, D N Poller.   

Abstract

AIMS: Evidence suggests that the presence of tumour necrosis is an adverse prognostic factor in renal cell carcinoma (RCC). However, it has also been shown that tumour regression, a microscopic feature associated with necrosis, may be a favourable short term prognostic factor in RCC.
METHODS: Pathology reports of 253 RCCs from 1992 to 2001 were reviewed, and identified 37 tumours with substantial macroscopic or microscopic necrosis. Microscopic pathology, TNM 1997 tumour stage, and clinical follow up were reviewed and correlated with pathological findings. Three cases were rejected because two were diagnosed at necropsy, and a third was the result of renal arterial embolisation.
RESULTS: Twenty of the 34 cases showed <50% necrosis, 10 showed 50-94% tumour necrosis, and four showed >95% tumour necrosis. Follow up data were unavailable in three cases. Nine of the remaining 31 tumours progressed; six were group 3 tumours showing <50% necrosis, three were group 2 tumours showing 50-94% necrosis, and none was a group 1 tumour showing >95% necrosis.
CONCLUSIONS: Extensive necrosis (>95% necrosis) is rare in RCC, accounting for only 1.6% of those diagnosed during eight years in this unselected hospital series. The microscopic pattern of necrosis was typical, requiring extensive tumour sampling for definitive tumour diagnosis. Although there were only four patients with extensive necrosis, none developed recurrent or metastatic carcinoma, or died from RCC. Although extensive (>95%) necrosis may imply better short term prognosis after adjusting for tumour pathological TNM stage, it is probably not a prognostic variable in RCC.

Entities:  

Mesh:

Year:  2005        PMID: 15623480      PMCID: PMC1770541          DOI: 10.1136/jcp.2004.018846

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases.

Authors:  Mahul B Amin; Mitual B Amin; Pheroze Tamboli; Javid Javidan; Hans Stricker; Mariza de-Peralta Venturina; Anita Deshpande; Mani Menon
Journal:  Am J Surg Pathol       Date:  2002-03       Impact factor: 6.394

2.  Prognostic significance of the Heidelberg classification of renal cell carcinoma.

Authors:  B Ljungberg; F I Alamdari; R Stenling; G Roos
Journal:  Eur Urol       Date:  1999-12       Impact factor: 20.096

3.  Stage pT1 conventional (clear cell) renal cell carcinmoa: pathological features associated with cancer specific survival.

Authors:  J C Cheville; M L Blute; H Zincke; C M Lohse; A L Weaver
Journal:  J Urol       Date:  2001-08       Impact factor: 7.450

4.  Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.

Authors:  R Childs; A Chernoff; N Contentin; E Bahceci; D Schrump; S Leitman; E J Read; J Tisdale; C Dunbar; W M Linehan; N S Young; A J Barrett
Journal:  N Engl J Med       Date:  2000-09-14       Impact factor: 91.245

5.  Extensively necrotic cystic renal cell carcinoma: a clinicopathologic study with comparison to other cystic and necrotic renal cancers.

Authors:  D A Brinker; M B Amin; M de Peralta-Venturina; V Reuter; D Y Chan; J I Epstein
Journal:  Am J Surg Pathol       Date:  2000-07       Impact factor: 6.394

6.  Extensive necrosis in renal cell carcinoma specimens: potential clinical and prognostic implications.

Authors:  I Leibovitch; R Lev; Y Mor; J Golomb; Z A Dotan; J Ramon
Journal:  Isr Med Assoc J       Date:  2001-08       Impact factor: 0.892

7.  Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma.

Authors:  John C Cheville; Christine M Lohse; Horst Zincke; Amy L Weaver; Michael L Blute
Journal:  Am J Surg Pathol       Date:  2003-05       Impact factor: 6.394

8.  An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score.

Authors:  Igor Frank; Michael L Blute; John C Cheville; Christine M Lohse; Amy L Weaver; Horst Zincke
Journal:  J Urol       Date:  2002-12       Impact factor: 7.450

9.  Spontaneous regression of renal cell carcinoma: a pitfall in diagnosis of renal lesions.

Authors:  Y Hamid; D N Poller
Journal:  J Clin Pathol       Date:  1998-04       Impact factor: 3.411

10.  Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.

Authors:  Bradley C Leibovich; Michael L Blute; John C Cheville; Christine M Lohse; Igor Frank; Eugene D Kwon; Amy L Weaver; Alexander S Parker; Horst Zincke
Journal:  Cancer       Date:  2003-04-01       Impact factor: 6.860

View more
  2 in total

Review 1.  Prognostic Factors for Localized Clear Cell Renal Cell Carcinoma and Their Application in Adjuvant Therapy.

Authors:  Kalle E Mattila; Paula Vainio; Panu M Jaakkola
Journal:  Cancers (Basel)       Date:  2022-01-04       Impact factor: 6.639

Review 2.  Necroptosis in Immuno-Oncology and Cancer Immunotherapy.

Authors:  Jenny Sprooten; Pieter De Wijngaert; Isaure Vanmeerbeerk; Shaun Martin; Peter Vangheluwe; Susan Schlenner; Dmitri V Krysko; Jan B Parys; Geert Bultynck; Peter Vandenabeele; Abhishek D Garg
Journal:  Cells       Date:  2020-08-01       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.